(IBTI) iShares iBonds Dec 2028 - Ratings and Ratios
Treasury,Bond,Fixed,Income,Maturity
Description: IBTI iShares iBonds Dec 2028 August 23, 2025
The iShares iBonds Dec2028 Term Treasury ETF (IBTI) is a target maturity ETF that tracks a specific segment of the US Treasury market, providing investors with a defined maturity schedule and a predictable income stream. As a Treasury ETF, its performance is closely tied to interest rates and the overall shape of the yield curve.
Key drivers of the funds performance include changes in US monetary policy, inflation expectations, and the overall demand for US Treasuries. The funds maturity profile, set to mature in December 2028, makes it sensitive to shifts in the yield curve, particularly in the 10-year to 15-year segment. As a result, investors should monitor the Federal Reserves actions, economic indicators such as GDP growth and inflation rates, and global events that impact US Treasury demand.
To evaluate the funds performance, investors can track key metrics such as yield to maturity, duration, and the funds tracking error relative to its benchmark. The funds yield to maturity is a critical KPI, as it reflects the total return an investor can expect if they hold the fund until maturity. Additionally, the funds duration, which measures its sensitivity to interest rate changes, is essential in assessing potential price volatility.
The funds assets under management (AUM) of $1.082 billion indicate a moderate level of investor interest. As a relatively liquid ETF, with an average trading volume of 155,300 shares, investors can enter or exit positions with relative ease. However, investors should remain aware of potential liquidity risks, particularly during periods of market stress.
To make informed investment decisions, investors should consider the funds characteristics, such as its maturity profile, yield, and duration, in the context of their overall investment objectives and risk tolerance. By doing so, they can effectively utilize IBTI as a component of a broader investment strategy, potentially benefiting from the funds predictable income stream and relatively low credit risk.
IBTI ETF Overview
| Market Cap in USD | 1,209m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2020-02-25 |
IBTI ETF Ratings
| Growth Rating | 54.8% |
| Fundamental | - |
| Dividend Rating | 76.3% |
| Return 12m vs S&P 500 | -7.24% |
| Analyst Rating | - |
IBTI Dividends
| Dividend Yield 12m | 3.55% |
| Yield on Cost 5y | 3.46% |
| Annual Growth 5y | 55.74% |
| Payout Consistency | 100.0% |
| Payout Ratio | % |
IBTI Growth Ratios
| Growth Correlation 3m | 89.2% |
| Growth Correlation 12m | 98.1% |
| Growth Correlation 5y | -24.8% |
| CAGR 5y | 4.37% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.81 |
| CAGR/Mean DD 3y (Pain Ratio) | 3.18 |
| Sharpe Ratio 12m | 0.58 |
| Alpha | -7.65 |
| Beta | 0.680 |
| Volatility | 1.88% |
| Current Volume | 316.5k |
| Average Volume 20d | 198.2k |
| Stop Loss | 21.6 (-3.4%) |
| Signal | 0.65 |
What is the price of IBTI shares?
Over the past week, the price has changed by +0.16%, over one month by +0.39%, over three months by +1.27% and over the past year by +5.77%.
Is iShares iBonds Dec 2028 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTI is around 21.22 USD . This means that IBTI is currently overvalued and has a potential downside of -5.14%.
Is IBTI a buy, sell or hold?
What are the forecasts/targets for the IBTI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 23.7 | 5.8% |
IBTI Fundamental Data Overview November 04, 2025
Beta = 0.68
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.21b USD (1.21b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.21b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.21b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.52% (E(1.21b)/V(1.21b) * Re(8.52%) + (debt-free company))
Discount Rate = 8.52% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle